Workday Inc. (NASDAQ: WDAY) Chief Financial Officer Zane Rowe reported multiple share disposals in early April 2026, according to a Form 4 filing with the Securities and Exchange Commission. On April 7, 2026, Rowe sold a combined 5,990 shares of Class A common stock for an aggregate of approximately $769,314. The transactions were transacted at prices between $127.6988 and $129.2601 per share.
Separately, the filing shows Rowe sold 9,140 shares on April 5, 2026. Those shares were used to satisfy tax obligations arising from the vesting of restricted stock units; they were valued at $132.26 apiece for a total of $1,208,856.
After accounting for these sales, Rowe's direct holdings in Workday Class A common stock total 217,930 shares. That figure incorporates 147,584 restricted stock units and 5,968 performance stock units that remain part of his position.
The sales on April 7 were carried out under a pre-established Rule 10b5-1 trading arrangement that Rowe adopted on March 7, 2025. The existence of such a plan indicates the disposals were scheduled according to a previously agreed framework rather than ad hoc trades.
Workday's share price context underscores the timing of these transactions. The stock was trading at $127.51 at the time the data was reported, down more than 40% year-to-date and trading near a 52-week low of $117.76.
In addition to executive trading activity, public filings and company announcements from the period reflect a mixed backdrop for the business. Workday reported solid results for the fourth quarter of fiscal 2026, meeting revenue forecasts and surpassing earnings expectations. Management attributed an improved operating margin in the quarter to a slower rate of hiring.
Despite the quarter's earnings outperformance, several research firms updated their views on the stock. DA Davidson lowered its price target to $125, citing guidance that it said fell short of revenue and profitability expectations. BMO Capital trimmed its target to $182, referencing uncertainty about the company's growth strategy amid developments in generative AI. Freedom Capital Markets also reduced its price objective to $210 while retaining a Buy rating, acknowledging Workday's strong financial performance but pointing to competitive pressures from AI.
Corporate governance and customer developments were also reported. Workday's board granted CEO Aneel Bhusri equity awards tied to performance metrics, including restricted stock units that vest over a four-year schedule. Separately, Fairview Health Services selected Workday to modernize its human resources and finance systems, planning a migration of 34,000 employees onto Workday's integrated platform.
Analysis available through InvestingPro was noted in filings and commentary as indicating the stock is undervalued, with more in-depth coverage available in the platform's Pro Research Report, one of more than 1,400 reports covering U.S. equities.